联合MRI、高分辨率结肠测压及比沙可啶与东莨菪碱随机试验显示便秘中结肠扩大的意义:RECLAIM研究
RECLAIM研究第一部分比较44名健康志愿者、43例便秘型肠易激综合征(IBS-C)和37例功能性便秘(FC)患者的MRI结肠容积、全肠道传输时间及高分辨率结肠测压(HRCM);第二部分为10天比沙可啶10 mg每日一次与东莨菪碱20 mg每日三次的随机交叉试验。结肠异常扩大可预测聚乙二醇后排空延迟、测压餐后反应受损及比沙可啶镇痛效果;比沙可啶较东莨菪碱增加排便但引起更多疼痛。
要点
- IBS-C和FC患者总结肠容积中位数大于健康志愿者,全肠道传输时间更长且聚乙二醇后排便延迟。
- 结肠异常扩大可预测聚乙二醇后排空显著延迟、HRCM餐后反应受损及比沙可啶后疼痛减轻。
- 比沙可啶较东莨菪碱增加排便次数但两组均引起更多疼痛。
核心结论
- 结肠异常扩大是便秘的重要特征,可预测喂养后测压反应受损及治疗反应。
- HRCM显示IBS-C患者传播性压力波活动减少。
研究设计与样本
- 第一部分:44名健康志愿者、43例IBS-C和37例FC患者完成排便日记和问卷,接受口服聚乙二醇(500-1000 mL)挑战,用MRI评估全肠道传输时间、结肠节段容积、动力指数及食糜标记运动,并记录聚乙二醇后排便时间,左半结肠HRCM在700 kcal餐前和餐后记录。
- 第二部分:患者进入随机交叉研究,比沙可啶10 mg每日一次与东莨菪碱20 mg每日三次各10天,评估每日疼痛和便秘。
主要发现
- 总结肠容积中位数(范围):IBS-C组776(595-1033),FC组802(633-951),健康志愿者组645(467-780),p<0.001。
- IBS-C患者较健康志愿者标记指数显著降低且HRCM传播性压力波活动减少。
- 与FC相比,IBS-C患者更焦虑且报告更多疼痛。
- 结肠异常扩大预测聚乙二醇挑战后排便显著延迟(p<0.02)、测压餐后反应受损及比沙可啶后疼痛减轻(p<0.05)。
- 比沙可啶较东莨菪碱增加排便但两组均引起更多疼痛(p<0.03)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Colonic motility in constipation can be assessed non-invasively using MRI. OBJECTIVE: To compare MRI with high-resolution colonic manometry (HRCM) for predicting treatment response. DESIGN: Part 1: 44 healthy volunteers (HVs), 43 patients with irritable bowel syndrome with constipation (IBS-C) and 37 with functional constipation (FC) completed stool diaries and questionnaires and underwent oral macrogol (500-1000 mL) challenge. Whole gut transit time (WGTT), segmental colonic volumes (CV), MRI-derived Motility Index and chyme movement by 'tagging' were assessed using MRI and time to defecation after macrogol recorded. Left colonic HRCM was recorded before and after a 700 kcal meal. Patients then proceeded to Part 2: a randomised cross-over study of 10-days bisacodyl 10 mg daily versus hyoscine 20 mg three times per day, assessing daily pain and constipation. RESULTS: Part 1: Total CVs median (range) were significantly greater in IBS-C (776 (595-1033)) and FC (802 (633-951)) vs HV (645 (467-780)), p<0.001. Patients also had longer WGTT and delayed evacuation after macrogol. IBS-C patients showed significantly reduced tagging index and less propagated pressure wave (PPW) activity during HRCM versus HV. Compared with FC, IBS-C patients were more anxious and reported more pain. Abnormally large colons predicted significantly delayed evacuation after macrogol challenge (p<0.02), impaired manometric meal response and reduced pain with bisacodyl (p<0.05).Part 2: Bisacodyl compared with hyoscine increased bowel movements but caused more pain in both groups (p<0.03). CONCLUSION: An abnormally large colon is an important feature in constipation which predicts impaired manometric response to feeding and treatment responses. HRCM shows that IBS-C patients have reduced PPW activity. TRIAL REGISTRATION NUMBER: The study was preregistered on ClinicalTrials.gov, Reference: NCT03226145.
引用
- Wilkinson-Smith V, Scott M, Menys A, et al. Combined MRI, high-resolution manometry and a randomised trial of bisacodyl versus hyoscine show the significance of an enlarged colon in constipation: the RECLAIM study. Gut. 2024. PMID: 39438126. doi:10.1136/gutjnl-2024-332755
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。